Vazoket

Вазокет Drug photo

The description is actual on 19.03.2015

  • Latin name: Vasocet
  • ATH code: C05CA03
  • Active ingredient: Diosmin (Diosmin)
  • Producer: Weimer Pharma GmbH (Germany)

Structure

In 1 tablet of diosmin of 600 mg.

Starch corn, povidone, microcrystallic cellulose, magnesium stearate — excipients.

Release form

Tablets.

Pharmacological action

Venotoniziruyushchy.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Diosmin thanks to active flavonoids has venotoniziruyushchy effect: raises a tone of veins, reduces distensibility and eliminates venous stagnation.

The Venotoniziruyushchy effect has dozozavisimy character. Vazoket improves a lymphatic drainage, raising a tone of lymphatic capillaries and frequency of their reduction, reducing pressure in a lymphatic bed.

Improves microcirculation, influencing permeability of capillaries, improves diffusion of oxygen and as a result the trophicity of fabrics improves. Has moderate antiagregantny effect, suppressing process of "sticking" of leukocytes to a wall of veins. Possesses antiinflammatory action (blocks synthesis of prostaglandins).

Pharmacokinetics

It is well soaked up from a gastrointestinal tract and in 2 hours the maximum concentration — in 5 hours is found in blood, and. Collects in walls of venas cava and outside veins of extremities. Selective accumulation of drug in veins remains 96 hours. Diosmin is removed mainly with urine, a stake and bile.

Indications to use

There are data that Vazoket can be appointed for prevention of bleedings which arise after introduction of intrauterine spirals, and also during a phlebectomy.

Contraindications

  • the age is less than 18 years;
  • hypersensitivity to drug;
  • lactation.

Side effects

Vazoket, application instruction (Way and dosage)

Vazoket 600 at lympho-venous insufficiency (peripheral) and a varicosity — on 1 tablet in the morning before meal. Course of treatment 2 months.

At the expressed lympho-venous insufficiency — 3-4 months, at trophic ulcers prolong till 6 months. Course treatment is repeated every 6 months.

At an exacerbation of hemorrhoids of 7 days to accept 2-3 tablets of times a day during food, then on 1 tablet a day 1-2 months. The application instruction of Vazoket contains a reminder that at an exacerbation of hemorrhoids treatment is carried out in a complex with other HP.

In the II—III trimester of pregnancy at venous insufficiency — 1 tablet a day. Drug is cancelled in 3 weeks prior to childbirth.

Overdose

Does not meet, symptoms are not described.

Interaction

Effects of interaction with other drugs are not described. During treatment alcohol intake is not recommended.

Terms of sale

It is released according to the recipe.

Storage conditions

In the dry place, it is not higher than 300 Pages.

Period of validity

3 years.

Vazoket's analogs

Analogs of Flebodia 600, Mediven, Diovenor 600, Diosmin, Flebofa have one active ingredient diosmin.

About Vazoketa

Clinical tests of Vazoket do not meet, it is possible to meet Flebodiya's research and Detralex more often. However, there are responses of the practicing phlebologists who appointed this drug at a varicosity. Analyzing comments of doctors on Vazoketa it is possible to draw a conclusion that at patients good tolerance of drug is noted, allergic reactions meet extremely seldom in spite of the fact that a course of treatment drug not less than 3 months 2 times a year.

The elastic compression (stockings, panty hoses or bandaging) was surely applied. At all patients reduction of expressiveness of symptoms of HVN, positive influence of drug on dynamics of healing of trophic ulcers was noted. Upon completion of a course of treatment the steady effect within 2 months on condition of carrying compression jersey remained.

Vazoket or Flebodia — what is better?

The concept "best" — collective from "effective", "safe", "available". Choosing means for treatment, it is necessary to compare all factors: active ingredient, possible side effects, duration of courses of treatment and cost of drugs.

The Flebodia and Vazoket have one active ingredient — a bioflavonoid diosmin which defines therapeutic action. The Flebodia (Innothera Chouzy, France) contains 600 mg of diosmin, Vazoket 600 also — 600 mg of diosmin and a little different excipients that is not so essential. The truth it is important for some patients as on components of drug there can be a reaction.

Vazoket's cost from 635 rub to 804 rub, and is slightly higher than Flebodia the 600th No. 30 — from 650 rub to 1046 rub.

It is considered to be that original drug (in this case — Flebodia) is better than generics. However, Weimer Pharma GmbH (Germany) — the producer Vazoketa takes the worthy place in the pharmaceutical market and as medicines of this company you should not doubt.

Drugs of Flebodia and Vazoket are identical by efficiency and possible side effects.

Zdravzona

  • Vazoket of 600 mg No. 30 of a tablet
to show still

Apteka24

  • Vazoket of a tablet 600 of mg No. 30 of Schwartz Farma (Germany)
Section: Cardiovascular
in more detail

Education: Graduated from Sverdlovsk medical school (1968 - 1971) as "Paramedic". Graduated from the Donetsk medical institute (1975 - 1981) as "An epidemiologist, a hygienist". Passed postgraduate study in the Central scientific research institute of epidemiology Moscow (1986 - 1989). An academic degree – the candidate of medical sciences (degree is awarded in 1989, protection – the Central scientific research institute of epidemiology Moscow). Numerous advanced training courses are studied in epidemiology and infectious diseases.

Experience: Work as the manager of department of disinfection and sterilization of 1981 - 1992. Work as the manager of department of especially dangerous infections of 1992 - 2010. Teaching activity at Medical institute 2010 - 2013.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use of Vazoket surely consult with the attending physician.